Skip to content
lifestyle.phenomena.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
GENFIT S.A.
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
July 2, 2026
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
June 23, 2026
GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026
May 25, 2026
GENFIT Reports First Quarter 2026 Financial Information and Provides a Corporate Update
May 21, 2026
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
February 12, 2026
←
Previous Page
1
2